Validea's guru fundamental report indicates that Gilead Sciences (GILD) receives a 90% rating based on their Earnings Yield Investor model, which is based on Joel Greenblatt's value investment strategy that seeks companies with high return on capital and earnings yields. The rating suggests strong interest in the stock based on its fundamentals and valuation, although both earnings yield and return on tangible capital are rated as neutral. Greenblatt's "Magic Formula" has historically demonstrated significant outperformance compared to the S&P 500.
Gilead Sciences, Inc. (GILD) has garnered a high 90% rating from Validea's Earnings Yield Investor model, which is based on Joel Greenblatt's published investment strategy focusing on companies with high return on capital and robust earnings yields. This score suggests strong interest in GILD according to this specific value-oriented model, particularly as scores above 80% are typically indicative of interest, and those above 90% signal strong interest. Despite this favorable overall assessment and passing the final ranking, individual metrics for GILD's "EARNINGS YIELD" and "RETURN ON TANGIBLE CAPITAL" are both rated as "NEUTRAL". The significance of Greenblatt's approach is underscored by the historical performance of his "Magic Formula," which reportedly achieved a 30.8% annualized return from 1988 through 2004, more than doubling the S&P 500's 12.4% return during that period. This context suggests that while the composite model views GILD favorably, the neutral ratings on these two fundamental components warrant careful consideration in assessing the company's investment profile.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment
